throbber
IPR2022-01147
`U.S. Patent No. 8,019,091
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`APPLE INC.,
`SAMSUNG ELECTRONICS CO., LTD., AND
`SAMSUNG ELECTRONICS AMERICA, INC.
`
`Petitioners
`v.
`
`JAWBONE INNOVATIONS, LLC,
`
`Patent Owner
`
`
`
`
`
`
`
`
`
`Case IPR2022-01147
`
`U.S. Patent No. 8,019,091
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PETITIONERS’ PRELIMINARY REPLY
`
`
`
`
`
`
`
`
`
`
`

`

`
`
`
`
`
`IPR2022-01147
`U.S. Patent No. 8,019,091
`
`LIST OF EXHIBITS
`
`EX-1001
`
`U.S. Patent No. 8,019,091 to Burnett et al. (“the ’091 patent”)
`
`EX-1002
`
`Prosecution History of the ’091 patent
`
`EX-1003
`
`Declaration of Dr. Thomas Kenny
`
`EX-1004
`
`U.S. Patent No. 6,415,034 to Hietanen (“Hietanen”)
`
`EX-1005
`
`U.S. Patent No. 6,377,919 to Burnett et al. (“Burnett”)
`
`EX-1006
`
`EX-1007
`
`Weinstein et al., “Multi-Channel Signal Separation by
`Decorrelation,” IEEE Transactions on Speech and Audio
`Processing, Vol. 1, No. 4, October 1993, pages 405-413
`(“Weinstein”)
`
`Gregory Burnett, The Physiological Basis of Glottal
`Electromagnetic Micropower Sensors (GEMS) and Their Use in
`Defining an Excitation Function for the Human Vocal Tract,
`Dissertation, January 1999 (“Burnett Thesis”)
`
`EX-1008
`
`Japanese Unexamined Patent Application JPH11305792 and
`Certified Translation (“Takano”)
`
`EX-1009
`
`U.S. Patent No. 5,282,253 to Konomi
`
`EX-1010
`
`U.S. Patent No. 5,295,193 to Ono
`
`EX-1011
`
`U.S. Patent No. 5,473,701 to Cezanne et al.
`
`Hussain et al., “A New Metric For Selecting Sub-band Processing
`In Adaptive Speech Enhancement Systems,” EuroSpeech ’97
`Proceedings, ESCA 5th European Conference On Speech
`Communication And Technology, September 22-25, 1997, pages
`2611-2614 (“Hussain”)
`
`EX-1012
`
`
`
`
`
`

`

`
`
`
`
`
`
`IPR2022-01147
`U.S. Patent No. 8,019,091
`
`
`EX-1013
`
`U.S. Patent No. 8,000,482 to Lambert et al.
`
`EX-1014
`
` Dani Kass, Fintiv Fails: PTAB Uses ‘Remarkably Inaccurate’
`Trial Dates, LAW360 (Nov. 2, 2021, 9:09 PM),
`https://www.law360.com/articles/1436071
`
`EX-1015
`
` Complaint – Jawbone Innovations, LLC v. Samsung Electronics
`Co., Ltd., et al., 2:21-cv-00186, D.I. 1 (E.D. Tex. May 27, 2021)
`
`EX-1016
`
`EX-1017
`
` First Amended Complaint – Jawbone Innovations, LLC v.
`Samsung Electronics Co., Ltd., et al., 2:21-cv-00186, D.I. 21 (E.D.
`Tex. Oct. 26, 2021)
`
` Ryan David, Positive COVID Tests Derail Intel Patent Trial In
`WDTX, LAW360 (Apr. 26, 2022, 1:16PM),
`https://www.law360.com/articles/1487451
`
`EX-1018
`
` Motion to Transfer (Public Version) – Jawbone Innovations, LLC
`v. Apple Inc., 6:21-cv-00984, D.I. 47 (W.D. Tex. May 6, 2022)
`
`EX-1019
`
` Motion to Transfer (Public Version) – Jawbone Innovations, LLC
`v. Google LLC, 6:21-cv-00985, D.I. 43 (W.D. Tex. Apr. 29, 2022)
`
`EX-1020
`
` Motion to Transfer – Jawbone Innovations, LLC v. Amazon.com,
`Inc., 2:21-cv-00435, D.I. 25 (E.D. Tex. Mar. 10, 2022)
`
`EX-1021
`
` Complaint – Jawbone Innovations, LLC v. Apple Inc., 6:21-cv-
`00984, D.I. 1 (W.D. Tex. Sep. 23, 2021)
`
`EX-1022
`
` Scheduling Order – Jawbone Innovations, LLC v. Apple Inc., 6:21-
`cv-00984, D.I. 23 (W.D. Tex. Jan. 7, 2022)
`
`EX-1023
`
` Order Setting Deadlines – Jawbone Innovations, LLC v. Samsung
`Electronics Co., Ltd., et al., 2:21-cv-00186, D.I. 28 (E.D. Tex.
`Dec. 14, 2021)
`
`
`
`
`
`
`3
`
`

`

`
`
`
`
`
`
`IPR2022-01147
`U.S. Patent No. 8,019,091
`
`
`EX-1024
`
` Docket Control Order – Jawbone Innovations, LLC v. Samsung
`Electronics Co., Ltd., et al., 2:21-cv-00186, D.I. 38 (E.D. Tex. Feb.
`1, 2022)
`
`EX-1025
`
`
`
`Initial Infringement Contentions for ’091 Patent – Jawbone
`Innovations, LLC v. Apple Inc., 6:21-cv-00984 (W.D. Tex. Jan. 13,
`2022)
`
`EX-1026
`
` Complaint – Jawbone Innovations, LLC v. Google LLC, 6:21-cv-
`00985, D.I. 1 (W.D. Tex. Sep. 23, 2021)
`
`EX-1027
`
` Press Release of U.S. Senator Patrick Leahy of Vermont
`
`EX-1028
`
` Legislative Proposal - Restoring the America Invents Act
`
`EX-1029
`
` Apple Sand Revolution Stipulation
`
`EX-1030
`
` Samsung Sotera Stipulation
`
`EX-1031
`
`Ryan Davis, Fintiv's Emergency Motion Delays Apple Patent Trial
`In WDTX, LAW360 (June 8, 2022, 8:17 PM), available at:
`https://www.law360.com/technology/articles/1500531/fintiv-s-
`emergency-motion-delays-apple-patent-trial-in-
`wdtx?nl_pk=0e88f4cd-71d1-4acd-9e72-
`7cac46756e13&utm_source=newsletter&utm_medium=email&ut
`m_campaign=technology&utm_content=2022-06-08
`
`EX-1032
`
`Declaration of June Ann Munford
`
`Amended Scheduling Order – Jawbone Innovations, LLC v. Apple
`Inc., 6:21-cv-00984, D.I. 107 (W.D. Tex. Oct. 10, 2022)
`
`Motion to Stay – Jawbone Innovations, LLC v. Samsung
`Electronics Co., Ltd., et al., 2:21-cv-00186, D.I. 106 (E.D. Tex.
`Aug. 8, 2022)
`
`4
`
`EX-1033
`
`EX-1034
`
`
`
`
`
`
`

`

`
`
`
`
`
`
`IPR2022-01147
`U.S. Patent No. 8,019,091
`
`
`I.
`INTRODUCTION
`As authorized by the Board, Petitioners below address the proper application
`
`of the Fintiv factors under the USPTO’s Interim Procedure for Discretionary Denials
`
`(“Guidance”), and demonstrate that denial would be inappropriate.
`
`II.
`DISCRETION SHOULD NOT PRECLUDE INSTITUTION
`Compelling Merits Alone Show Discretionary Denial Is Not Appropriate.
`
`As demonstrated in the Petition with reference to Dr. Kenny’s testimony and
`
`additional supporting evidence, the Petition’s merits are “compelling,” and this
`
`“alone demonstrates that the PTAB should not discretionarily deny institution under
`
`Fintiv.” Guidance, 3-5. Dr. Kenny extensively explains, for example, how and why
`
`a POSITA would have combined the applied references, and the mappings of the
`
`resulting combinations to each limitation of the Challenged Claims.
`
`In contrast, the POPR relies upon unsupported attorney argument, improperly
`
`argues references individually, and ignores disclosures about which Dr. Kenny
`
`testified. The strength of the merits is enough to outweigh any inefficiencies born
`
`of parallel litigation. Guidance, 3-5, 9; Fintiv, 14-15. Accordingly, Petitioners
`
`respectfully submit that the Petition should be considered and instituted on its merits.
`
`The Co-Pending Litigations Have Different Procedural Postures. As
`
`addressed in the Petition, the Samsung and Apple litigations are proceeding in
`
`different jurisdictions (Samsung in EDTX and Apple in WDTX). Apple’s motion
`
`
`
`
`1
`
`

`

`
`
`
`
`
`
`for transfer to NDCA remains pending. EX-1038.
`
`IPR2022-01147
`U.S. Patent No. 8,019,091
`
`
`The Fintiv Factors Are Inapplicable to the Samsung Litigation. Samsung’s
`
`Sotera stipulation fully resolves consideration of Fintiv for the Samsung litigation.
`
`Pet. 82; EX-1026; Guidance, 7. Specifically, the Guidance notes that “the PTAB will
`
`not discretionarily deny institution of an IPR or PGR in view of parallel district court
`
`litigation where a petitioner” provides a Sotera stipulation. Guidance, 7.
`
`The Fintiv Factors for the Samsung and Apple Litigations Strongly Favor
`
`Institution. The Guidance clarifies that Samsung’s Sotera stipulation fully resolves
`
`consideration of Fintiv for the Samsung litigation; consequently, the Board need not
`
`reach the Fintiv factors with respect to that litigation. Nevertheless, Petitioners
`
`below address the Samsung and Apple litigations individually with respect to the
`
`Fintiv factors, and in so doing demonstrate that the factors weigh heavily against
`
`discretionary denial for both litigations. Pet. 74-75; Shenzhen Carku Tech. Co., Ltd.
`
`v. The Noco Co., IPR2020-00944, Paper 20, 56 (Nov. 12, 2020).
`
`1. Likelihood of district court stay. Samsung has requested a stay of the
`
`parallel litigation and that request remains pending. EX-1034. Neither party to the
`
`Apple litigation has yet requested a stay, but a stay remains possible. Indeed, Apple’s
`
`motion for transfer to NDCA remains pending and, if granted, stay pending
`
`institution is likely. Nevertheless, upon institution of this petition and regardless of
`
`the transfer decision, Apple intends to file a motion to stay the parallel litigation.
`2
`
`
`
`
`

`

`
`
`
`
`
`
`IPR2022-01147
`U.S. Patent No. 8,019,091
`
`
`Accordingly, as noted in the Petition, Fintiv Factor 1 is at worst neutral (Pet. 75).
`
`2. Trial Date Relative to Final Written Decision Due Date.
`
`The Guidance is clear on the trial date to use when considering discretionary
`
`denial on the basis of co-pending litigation. Specifically, page 3 of the Guidance
`
`explains that “when considering the proximity of the district court’s trial date to the
`
`date when the PTAB final written decision will be due, the PTAB will consider the
`
`median time from filing to disposition of the civil trial for the district in which the
`
`parallel litigation resides,” and cited statistics. These statistics1 show “median time-
`
`to-trial” in EDTX as 24.5 months, and in WDTX as 28.3 months.
`
`The complaint against Apple was filed on September 23, 2021 (EX-1021),
`
`establishing an expected trial date of late January or early February 2024 based on
`
`the WDTX statistics. The expected trial date thus falls after the statutory deadline
`
`for the Board’s FWD, which is expected to be no later than January 7, 2024.
`
`Patent Owner asks the Board to ignore this guidance and, instead, use the
`
`July 26, 2023 trial date in the Apple litigation scheduling order entered on January
`
`7, 2022. POPR, 27. However, as the Director explained “scheduled trial dates are
`
`
`
` Available at https://www.uscourts.gov/statistics/table/na/federal-court-
`
` 1
`
`management-statistics/2022/06/30-2.
`
`
`
`
`3
`
`

`

`
`
`
`
`
`
`IPR2022-01147
`U.S. Patent No. 8,019,091
`
`
`unreliable and often change.” Guidance, 8. Indeed, the district court for the Apple
`
`litigation recently delayed trial to September 27, 2023 in the amended scheduling
`
`order entered on October 20, 2022. EX-1033, 3. That a Markman hearing has not
`
`yet been held, and that Apple’s motion to transfer remains pending, further
`
`underscores the uncertainty as to whether and when the Apple litigation might
`
`proceed to trial. Thus, the Board should follow the Guidance, i.e., use median time
`
`to trial, and find Factor 2 to favor institution with respect to the Apple litigation.
`
`As noted above, the Guidance clarifies that Samsung’s Sotera stipulation
`
`fully resolves consideration of Fintiv for the Samsung litigation; consequently, the
`
`Board need not reach this factor for that litigation. Pet. 81; EX-1026; Guidance, 7.
`
`3. Investment in the Parallel Proceeding and Petitioner’s Diligence. As
`
`noted in the Petition (Pet. 77-79), Factor 3 weighs strongly against discretionary
`
`denial. PO does not dispute that Samsung and Apple were diligent in filing this
`
`Petition. See POPR 29-30. As to investment, for the Samsung litigation, Samsung’s
`
`Sotera stipulation will mitigate any investment as to overlapping issues. As to the
`
`Apple litigation, the deadline for final contentions has not yet passed, a Markman
`
`hearing has not yet been held (and is not currently scheduled to take place until May
`
`2023), and Apple’s motion to transfer remains pending. EX-1033, 1.
`
`4. Overlap of Issues. As noted in the Petition (Pet. 80-81), Factor 4 weighs
`
`strongly against discretionary denial, at least because any grounds that might be
`4
`
`
`
`
`

`

`
`
`
`IPR2022-01147
`U.S. Patent No. 8,019,091
`
`raised in litigation are materially different from those presented in the Petition.
`
`
`
`
`Samsung provided a Sotera stipulation. Pet. 81; EX-1026.2
`
`PO’s argument that Apple has not provided a Sotera stipulation does not
`
`change the weight that should be accorded to Apple’s Sand Revolution stipulation,
`
`which resolves doubt as to meaningful overlap of issues (Pet. 81; EX-1025). For
`
`example, Apple’s stipulation requires the grounds addressed in each forum to be
`
`mutually exclusive, thereby obviating the possibility of inconsistent results.
`
`Furthermore, WDTX has set 2023 deadlines for “meet and confers to discuss
`
`significantly narrowing the number of claims asserted and prior art references at
`
`issue to triable limits.” EX-1033, 2. Accordingly, as litigation progresses, overlap in
`
`claim coverage and/or prior art is almost certain to reduce even more.
`
`6. Other Considerations. Petitioners respectfully submit that the Fintiv factors
`
`weigh heavily against the Board exercising its discretion to deny institution. Indeed,
`
`the Petition’s merits are “compelling,” and this “alone demonstrates that the PTAB
`
`should not discretionarily deny institution under Fintiv.” Guidance, 3-5.
`
`
`
`
`
` The POPR also relies on the Google action, but Google is an unrelated party to
`
` 2
`
`Petitioners here. POPR, 30.
`
`
`
`
`5
`
`

`

`
`
`
`Date: November 2, 2022
`
`
`
`
`IPR2022-01147
`U.S. Patent No. 8,019,091
`
`
`Respectfully submitted,
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Andrew B. Patrick/
`
`Andrew B. Patrick (Reg. No. 63,471)
`Fish & Richardson P.C.
`3200 RBC Plaza, 60 South Sixth Street
`Minneapolis, MN 55402
`T: 202-783-5070
`F: 877-769-7945
`
`Counsel for Petitioners
`
`
`
`6
`
`
`
`
`
`
`
`
`
`
`

`

`
`
`
`
`
`
`IPR2022-01147
`U.S. Patent No. 8,019,091
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR § 42.6(e), the undersigned certifies that on November 2,
`
`2022, a complete and entire copy of this Petitioners’ Preliminary Reply was provided
`
`via email to the Patent Owner by serving the correspondence email addresses of
`
`record as follows:
`
`
`Peter Lambrianakos, plambrianakos@fabricantllp.com
`Vincent J. Rubino III, vrubino@fabricantllp.com
`Alfred R. Fabricant, ffabricant@fabricantllp.com
`Enrique W. Iturralde, eiturralde@fabricantllp.com
`Richard Cowell, rcowell@fabricantllp.com
`
`FABRICANT LLP
`411 Theodore Fremd Avenue, Suite 206
`South Rye, New York 10580
`Tel. 212-257-5797
` Fax. 212-257-5796
`ptab@fabricantllp.com
`
`
`
`
`
`
`
`
`
`
`
`
`/Crena Pacheco/
`Crena Pacheco
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`(617) 956-5938
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`7
`
`
`
`
`
`
`
`
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket